Financials Braskem S.A.

Equities

BRKM5

BRBRKMACNPA4

Commodity Chemicals

Market Closed - Sao Paulo 04:07:41 2024-04-26 pm EDT 5-day change 1st Jan Change
22.81 BRL +1.24% Intraday chart for Braskem S.A. +2.29% +4.35%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 24,521 19,504 45,482 19,609 17,347 17,837 - -
Enterprise Value (EV) 1 60,375 59,264 84,361 19,609 73,323 57,975 55,183 51,391
P/E ratio -8.49 x -2.8 x 3.28 x -56.4 x -3.8 x -8.25 x 15.9 x 6.13 x
Yield 2.82% - 14.1% - - - - 4.04%
Capitalization / Revenue 0.47 x 0.33 x 0.43 x 0.2 x 0.25 x 0.23 x 0.22 x 0.21 x
EV / Revenue 1.15 x 1.01 x 0.8 x 0.2 x 1.04 x 0.76 x 0.67 x 0.6 x
EV / EBITDA 16.9 x 5.4 x 2.44 x 1.85 x 19.6 x 8.42 x 5.28 x 4.2 x
EV / FCF -145 x 16.8 x 7.42 x - -10.8 x 14.9 x 9.51 x 6.64 x
FCF Yield -0.69% 5.96% 13.5% - -9.28% 6.73% 10.5% 15.1%
Price to Book 4.86 x -8.52 x 5.83 x - 4.36 x 7.28 x 3.4 x 2.27 x
Nbr of stocks (in thousands) 795,742 795,744 796,066 796,303 796,968 796,968 - -
Reference price 2 29.85 23.57 57.63 23.76 21.86 22.81 22.81 22.81
Announcement Date 4/4/20 3/11/21 3/16/22 3/22/23 3/19/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 52,324 58,543 105,625 96,519 70,569 76,583 82,848 86,004
EBITDA 1 3,576 10,975 34,507 10,571 3,737 6,887 10,455 12,249
EBIT 1 -57 -72 26,044 5,838 -1,469 2,036 5,680 7,557
Operating Margin -0.11% -0.12% 24.66% 6.05% -2.08% 2.66% 6.86% 8.79%
Earnings before Tax (EBT) 1 -4,803 -9,684 17,961 47 -6,192 -3,616 1,180 3,003
Net income 1 -2,798 -6,692 14,000 -336 -4,579 -2,087 1,059 2,924
Net margin -5.35% -11.43% 13.25% -0.35% -6.49% -2.72% 1.28% 3.4%
EPS 2 -3.515 -8.407 17.57 -0.4215 -5.746 -2.765 1.435 3.722
Free Cash Flow 1 -417.2 3,533 11,365 - -6,802 3,900 5,806 7,737
FCF margin -0.8% 6.03% 10.76% - -9.64% 5.09% 7.01% 9%
FCF Conversion (EBITDA) - 32.19% 32.94% - - 56.63% 55.53% 63.16%
FCF Conversion (Net income) - - 81.18% - - - 548.47% 264.6%
Dividend per Share 2 0.8404 - 8.145 - - - - 0.9214
Announcement Date 4/4/20 3/11/21 3/16/22 3/22/23 3/19/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 28,299 28,212 26,731 25,411 25,387 18,990 19,446 17,756 16,676 16,691 17,631 17,429 17,669 17,515 -
EBITDA 1 8,629 7,682 4,845 3,927 1,967 -168 1,063 703 921 1,049 1,297 1,838 1,869 2,155 2,566
EBIT 1 7,670 3,722 3,844 1,654 691 -1,599 -167 -601 -364 -337 9.475 186.7 325.9 605.2 -
Operating Margin 27.1% 13.19% 14.38% 6.51% 2.72% -8.42% -0.86% -3.38% -2.18% -2.02% 0.05% 1.07% 1.84% 3.46% -
Earnings before Tax (EBT) 1 3,416 1,248 5,018 -1,738 -1,005 -2,227 144.2 -1,480 -3,030 -1,827 -1,856 -819 -696.9 -423.7 -
Net income 1 3,537 500 3,884 -1,406 -1,103 -1,710 184 -771 -2,418 -1,575 -1,507 -580.6 -499 -320.2 -
Net margin 12.5% 1.77% 14.53% -5.53% -4.34% -9% 0.95% -4.34% -14.5% -9.44% -8.55% -3.33% -2.82% -1.83% -
EPS 2 4.444 0.6659 4.879 -1.764 -1.384 -2.153 0.2309 -0.9674 -3.034 -1.975 -1.393 -0.9294 -0.7380 -0.5414 0.5800
Dividend per Share 2 7.539 8.145 - - - - - - - - - - - - -
Announcement Date 11/9/21 3/16/22 5/11/22 8/10/22 11/9/22 3/22/23 5/8/23 8/9/23 11/9/23 3/19/24 - - - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 35,855 39,760 38,879 - 55,976 40,137 37,346 33,554
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 10.03 x 3.623 x 1.127 x - 14.98 x 5.828 x 3.572 x 2.739 x
Free Cash Flow 1 -417 3,533 11,365 - -6,802 3,900 5,806 7,737
ROE (net income / shareholders' equity) -47.9% -499% 494% - -62.4% -88.2% 24.9% 62.3%
ROA (Net income/ Total Assets) -4.39% -8.68% 15.7% - -3.93% -2.13% 0.88% 2.65%
Assets 1 63,672 77,110 89,420 - 116,523 98,199 120,149 110,548
Book Value Per Share 2 6.140 -2.770 9.880 - 5.010 3.130 6.720 10.00
Cash Flow per Share 2 2.850 7.910 18.50 - -2.850 4.310 9.220 7.930
Capex 1 2,683 2,760 3,421 - 4,530 2,355 2,963 3,431
Capex / Sales 5.13% 4.71% 3.24% - 6.42% 3.08% 3.58% 3.99%
Announcement Date 4/4/20 3/11/21 3/16/22 3/22/23 3/19/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
22.81 BRL
Average target price
29.5 BRL
Spread / Average Target
+29.33%
Consensus
  1. Stock Market
  2. Equities
  3. BRKM5 Stock
  4. Financials Braskem S.A.